Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance.
Campistol JM, Albanell J, Arns W, Boletis I, Dantal J, de Fijter JW, Mortensen SA, Neumayer HH, Øyen O, Pascual J, Pohanka E, Schena FP, Serón D, Sparacino V, Chapman JR.
Campistol JM, et al. Among authors: pascual j.
Nephrol Dial Transplant. 2007 May;22 Suppl 1:i36-41. doi: 10.1093/ndt/gfm090.
Nephrol Dial Transplant. 2007.
PMID: 17456617
Review.